← Back to Search

Behavioral Intervention

Dissonance-Based Obesity Prevention + Response and Attention Training for Obesity (PH Trial)

N/A
Waitlist Available
Led By Eric M Stice, Ph.D.
Research Sponsored by Oregon Research Institute
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be younger than 65 years old
Must not have
Current diagnosis of anorexia nervosa
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline, 2 months, 8 months, 14 months, 26 months, and 38 months
Awards & highlights
No Placebo-Only Group

Summary

This trial is testing whether a novel obesity prevention program is more effective when done in single-sex versus mixed-sex groups, and whether adding food response and attention training increases weight gain prevention effects.

Who is the study for?
This trial is for late adolescents with a BMI between 20 and 30 who are moderately to extremely concerned about their weight. It's not open to individuals diagnosed with anorexia, bulimia, or binge eating disorder.
What is being tested?
The study tests a dissonance-based obesity prevention program in single- vs mixed-sex groups and adds food response and attention training. The goal is to see if these methods can prevent weight gain more effectively.
What are the potential side effects?
Since this isn't a drug trial but rather a behavioral intervention, typical medication side effects aren't expected. Participants may experience discomfort from discussing weight concerns or changing dietary habits.

Eligibility Criteria

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I have been diagnosed with anorexia nervosa.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline, 2 months, 8 months, 14 months, 26 months, and 38 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline, 2 months, 8 months, 14 months, 26 months, and 38 months for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Body Fat
Secondary study objectives
Beck Depression Index (BDI)
Eating Disorder Interview (EDDI)
Weight Concerns Scale from the Eating Disorder Examination Questionnaire (EDE-Q)

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

6Treatment groups
Experimental Treatment
Group I: Mixed Group, Generic Response TrainingExperimental Treatment2 Interventions
Participants in this arm will be assigned to receive Project Health in mixed-sex groups and will complete the generic response and attention training intervention.
Group II: Mixed Group, Food Response TrainingExperimental Treatment2 Interventions
Participants in this arm will be assigned to receive Project Health in mixed-sex groups and will complete the food-focused response and attention training intervention.
Group III: Male Group, Generic Response TrainingExperimental Treatment2 Interventions
Participants in this arm will be assigned to receive Project Health in male-only groups and will complete the generic response and attention training intervention.
Group IV: Male Group, Food Response TrainingExperimental Treatment2 Interventions
Participants in this arm will be assigned to receive Project Health in male-only groups and will complete the food-focused response and attention training intervention.
Group V: Female Group, Generic Response TrainingExperimental Treatment2 Interventions
Participants in this arm will be assigned to receive Project Health in female-only groups and will complete the generic response and attention training intervention.
Group VI: Female Group, Food Response TrainingExperimental Treatment2 Interventions
Participants in this arm will be assigned to receive Project Health in female-only groups and will complete the food-focused response and attention training intervention.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Project Health
2023
N/A
~430

Find a Location

Who is running the clinical trial?

Drexel UniversityOTHER
155 Previous Clinical Trials
47,816 Total Patients Enrolled
30 Trials studying Obesity
6,211 Patients Enrolled for Obesity
Oregon Research InstituteLead Sponsor
86 Previous Clinical Trials
62,488 Total Patients Enrolled
9 Trials studying Obesity
2,222 Patients Enrolled for Obesity
Eric M Stice, Ph.D.Principal InvestigatorOregon Research Institute

Media Library

Project Health (Behavioral Intervention) Clinical Trial Eligibility Overview. Trial Name: NCT03710746 — N/A
Obesity Research Study Groups: Mixed Group, Food Response Training, Mixed Group, Generic Response Training, Female Group, Generic Response Training, Male Group, Generic Response Training, Male Group, Food Response Training, Female Group, Food Response Training
Obesity Clinical Trial 2023: Project Health Highlights & Side Effects. Trial Name: NCT03710746 — N/A
Project Health (Behavioral Intervention) 2023 Treatment Timeline for Medical Study. Trial Name: NCT03710746 — N/A
~21 spots leftby Mar 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top